Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS USA

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 40
  • 0 comments

FDA approve DULOXETINE HYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve CABAZITAXEL

Comment Full text

AZURITY

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 28
  • 0 comments

FDA approve METARAMINOL BITARTRATE

Comment Full text

ABBVIE

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve BIMATOPROST

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 36
  • 0 comments

FDA approve PROPRANOLOL HYDROCHLORIDE

Comment Full text

MLV

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 39
  • 0 comments

FDA approve CARVEDILOL

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 29
  • 0 comments

FDA approve ASPIRIN; BUTALBITAL; CAFFEINE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Oct. 11, 2024, 04:30 UTC
  • 42
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 40
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 44
  • 0 comments

FDA approve PACLITAXEL

Comment Full text
  • Previous
  • 289
  • 290
  • 291
  • 292
  • 293
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2021)
  • SEC News(184942)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122482)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin